Risks Associated With Using Sulfonylureas As A Treatment For Type 2 Diabetes
Share This:
                           

About The Author

Dr. Suissa’s research is in pharmacoepidemiology which involves studying the risks and benefits of medications at the within the population at large. He specializes in the exploitation of existing computerized health databases to rapidly evaluate these risks. He has developed, and published extensively on, new methods of data analysis and study design that allow more rapid and accurate assessments of drug safety. He has conducted pharmacoepidemiological studies of several medications used for the treatment of chronic diseases, including asthma and COPD, cardiovascular and rheumatic diseases, and women’s health issues. He has lectured extensively throughout the world, and is the author of more than 360 peer-reviewed research papers published in scientific journals.

                       

Risks Associated With Using Sulfonylureas As A Treatment For Type 2 Diabetes

Sulfonylureas are antidiabetic drugs that have been used for more than 50 years in the treatment of type 2 diabetes. While sulfonylureas can effectively reduce elevated blood sugar levels found in patients with type 2 diabetes, they have also been linked to adverse events, such as hypoglycemia. This is important given that severe forms of hypoglycemia are known to increase the risk of cardiovascular disease and death. To better characterize the safety profile of sulfonylureas, we initiated a research project...

Read more